Investec Bank Plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure was made in Investec’s capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer party named in the filing.
The dealing was undertaken on 22nd October 2026, with the formal disclosure date recorded as 23rd October 2026.
The transaction involved the purchase of 118,491 ordinary shares in Advanced Medical Solutions Group Plc on the open market.
The highest price paid per unit during the transaction was 282.27p, while the lowest price per unit paid came in at 282.1p.
The narrow spread between the highest and lowest prices indicates the purchase was executed efficiently within a tight trading range during the session.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that may constitute an inducement to deal or refrain from dealing in relation to the offer.
The bank also stated there are no agreements or understandings relating to voting rights or the future acquisition or disposal of relevant securities to which any derivative is referenced.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service in a timely manner.
The contact named in the filing is Priyali Bhattacharjee, with a listed telephone number of +91-9768034903 for any related enquiries.
